LeMaitre Vascular (NSDQ:LMAT) this week ponied up $11 million in cash and another $3 million in post-closing payments for the vascular clot business at Applied Medical Resources Corp. The Burlington, Mass.-based company said the $14.2 million deal includes a one-year transition services provision that will see Applied Medical manufacture the devices for LeMaitre. The deal covers […]
Applied Medical this week released results from a meta-analysis study of wound protectors used during lower gastro intestinal procedures, touting their ability to reduce surgical site infections. Results from the study were published this month in the journal Surgical Endoscopy, the Rancho Santa Margarita, Calif.-based company said. Data from the analysis, which examined 12 randomized […]
Group purchasing organization Premier said it signed a raft of supply deals for a variety of medical device products.
The Charlotte-based GPO said it signed deals for endomechanical, trocar, suture and topical skin adhesives with 16 companies.
UPDATED 10/12/2011 with comments from Covidien
A Texas jury handed Applied Medical Resources a win over Covidien plc (NYSE:COV) in a long-running patent spat over surgical trocars, ruling that AMR does not infringe the patents and that they’re invalid, anyway.
The trial in the U.S. District Court for Eastern Texas, which wrapped up Oct. 7, is the latest front in the dispute between the two firms.
A federal judge in Texas “has a hard time” with arguments presented by Covidien plc (NYSE:COV) in its long-running patent spat with Applied Medical Resources over surgical trocars.
The latest in a series of lawsuits between Applied Medical Resources Corp. and Covidien plc (NYSE:COV) is slated to go before a jury later this month, after a federal judge in Texas denied AMR’s motion for summary judgment in the case.
A group of at least 57 product liability lawsuits filed against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics over one of its metal-on-metal hip implants were consolidated in the U.S. District Court for Northern Texas.
A federal judge in Texas upheld a $4.8 million verdict from Texas jury in a patent infringement lawsuit filed by Covidien plc (NYSE:COV) against Applied Medical Resources Corp. but denied Covidien’s bid for a permanent injunction against future sales of the infringing products.
Applied Medical Resources Corp. isn’t giving up on a patent infringement lawsuit filed against it by Covidien plc (NYSE:COV), despite a jury’s verdict last month awarding nearly $5 million to the Mansfield, Mass.-based medical products conglomerate.
A jury in the U.S. District Court for Eastern Texas sided with Covidien March 22, awarding damages of $4.8 million in a dispute over Norwalk, Conn.-based AMR’s Kii and Universal Seal laparoscopic trocars. Covidien, which filed the suit under the name of its corporate predecessor Tyco Healthcare Group, alleged that the devices infringed five of its patents.